中文If you’ve ever picked up a prescription and thought about the little label on the bottle, you’re not alone. Pharmaceutical packaging is one of those things most people don’t think about until something goes wrong. But Avery Dennison is thinking about it constantly — and their recent award at InnoPack Pharma Confex 2026 proves they’re ahead of the curve.
Avery Dennison took home the award in the Advance Packaging Material Category at InnoPack Pharma Confex 2026, held June 18-19 in Mumbai. It’s not just a nice trophy for the shelf. It’s recognition that packaging materials are evolving from passive containers into active, intelligent components of the healthcare supply chain.
The pharmaceutical industry is facing a perfect storm of challenges right now. Counterfeit drugs are a global problem worth billions. Supply chain visibility is more critical than ever. Patient safety depends on accurate tracking and authentication. And regulators worldwide are tightening requirements faster than many companies can adapt.
Avery Dennison’s showcase at the event brought together advanced functional materials, RFID-enabled technologies, and authentication solutions that address exactly these pain points. We’re talking about packaging that doesn’t just hold a product — it verifies it, tracks it, and protects it throughout its journey from factory to patient.
Jitesh Mehta, senior director of marketing for South Asia at Avery Dennison, captured the bigger picture perfectly: “The pharmaceutical industry is increasingly looking at packaging as a strategic tool, whether it is strengthening traceability, supporting patient safety or enabling greater visibility across the supply chain.”
That shift in thinking — from packaging as a cost center to packaging as a strategic enabler — is what this award is really about.
The conversations at InnoPack Pharma Confex highlighted some clear trends that are reshaping the industry. Digitalization is no longer optional. Supply chain transparency is becoming a regulatory requirement, not a nice-to-have. Sustainability is moving from marketing speak to mandatory compliance. And patient-centric packaging design is finally getting the attention it deserves.
Avery Dennison’s engagement at the event focused on how materials science and intelligent identification technologies can help pharmaceutical companies navigate this new landscape. From RFID tags that enable real-time tracking to advanced adhesives that perform under extreme conditions, the company’s portfolio is designed for an industry where failure isn’t an option.
For pharmaceutical manufacturers, the message is clear: your packaging choices are no longer just about containing and identifying your product. They’re about protecting your brand, ensuring patient safety, and meeting increasingly complex regulatory requirements. Companies that get this right will have a competitive advantage. Companies that don’t will face serious consequences.
Avery Dennison’s award is a reminder that in pharma packaging, innovation isn’t optional — it’s survival.
Source: Labels & Labeling
